Skip to content
Disclosery

&PARTNERS: CGCV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of &PARTNERS on CGCV, newest first. How the timeline and the estimate are built.

&PARTNERS held 339,871 CGCV shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 339,871 shares
    Change vs previous 13F +29,844 shares

    0.05% of the 13F portfolio, value $11,197,888.

    13F-HR 0001214659-26-010148 filed by &PARTNERS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 310,027 shares
    Change vs previous 13F +95,931 shares

    0.05% of the 13F portfolio, value $9,241,890.

    13F-HR 0001214659-26-006256 filed by &PARTNERS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 214,096 shares
    Change vs previous 13F +199,794 shares

    0.04% of the 13F portfolio, value $6,923,150.

    13F-HR 0001214659-26-001828 filed by &PARTNERS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 14,302 shares
    Change vs previous 13F +3,047 shares

    <0.01% of the 13F portfolio, value $436,229.

    13F-HR 0001214659-25-016487 filed by &PARTNERS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 11,255 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $321,893.

    13F-HR 0001214659-25-012047 filed by &PARTNERS
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).